$MEHA·8-K

Functional Brands Inc. · May 20, 5:00 PM ET

Compare

Functional Brands Inc. 8-K

Research Summary

AI-generated summary

Updated

Functional Brands Inc. Appoints New CFO; Former CFO Resigns from Board

What Happened

  • Functional Brands Inc. (MEHA) filed an 8-K reporting that on May 17, 2026, Tariq Rahim resigned from the Company’s Board effective immediately. Effective May 18, 2026, Mr. Rahim also ceased serving as Chief Financial Officer and transitioned to a non-executive role as Vice President, Finance. The filing states his departures were not due to any disagreement with the Company regarding operations, policies or financial reporting.
  • In connection with that transition, David R. Wells (age 63) was appointed effective May 18, 2026 as the Company’s Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer and as a member of the Board pursuant to a unanimous written consent approved May 19, 2026.

Key Details

  • Dates: Tariq Rahim’s board resignation dated May 17, 2026; CFO transition and Mr. Wells’ appointment effective May 18, 2026 (consent approved May 19, 2026).
  • Background on David R. Wells: director of HeartSciences, Inc. since Dec 2022; CFO of Envoy Medical, Inc. (Aug 2023–May 2025); founder/partner of Atlas Bookkeeping (Oct 2022); prior CFO roles at GHS Investments and ENDRA Life Sciences; MBA (Pepperdine) and BS (Seattle Pacific).
  • Compensation/agreements: No material employment or compensation agreement with Mr. Wells has been entered at filing; the Company will amend the 8-K if a material arrangement is later made.
  • Related-party: No family relationships or reportable transactions involving Mr. Wells under Item 404(a) of Regulation S-K.

Why It Matters

  • Governance and financial reporting roles changed immediately: investors should note the replacement of the Company’s CFO and addition to the Board, which affects who will oversee financial reporting and investor communications.
  • There is no indication in the filing of disputes or accounting disagreements related to the change, and no material compensation terms for the new CFO have been disclosed yet — a potential follow-up item for investors monitoring executive stability and costs.

Loading document...